Variant · Snv
RB1 NM_000321.3(RB1):c.1390-14A>T
CI-VAR-00025890Explore in graph →NM_000321.3:c.1390-14A>TClinVar 167566 rs9535023
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 167566 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts | 2 | Retinoblastoma; Hereditary cancer-predisposing syndrome; Uterine corpus endometrial carcinoma; Cholangiocarcinoma; Hereditary retinoblastoma; Malignant lymphoma, large B-cell, diffuse; Sarcoma; Ovarian serous cystadenocarcinoma; Uterine carcinosarcoma; Clear cell carcinoma of kidney; Thymoma; Cervical cancer | germline | 18 | Jun 24, 2026 | clinvar |